Trial intelligence / Profile preview

SUN11031 in COPD-associated cachexia

NCT00698828Phase 2Completed

Sponsor
Daiichi Sankyo Co., Ltd.
Start
May 2008
Primary completion
Oct 2009
Countries
6
01

Overview

Phase 2, randomised, double-blind trial of SUN11031 in cachexia, sponsored by Daiichi Sankyo Co., Ltd. Started May 2008; status: completed.

02

Drugs

SUN11031
03

Conditions

cachexia

Beyond the preview

Go deeper on NCT00698828.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00698828.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call